From DNA to Therapeutic Protein in CHO Cells (Full Video)
In 1957, a sample of cells from the ovary of a Chinese hamster was cultured and described. Unknowingly, the scientists establishing the Chinese Hamster Ovary (CHO) cells had kicked off a revolution within the field of biotech and biosynthesis of therapeutic proteins.
Today, most of the therapeutic proteins on the market are produced in large scale bioreactors using CHO cells derived from that same cell line from 1957.
Although cell culture methods and resulting yields have improved tremendously since the first recombinant proteins were made from CHO cells in 1978, we continue to see breakthroughs today.
One such breakthrough was contributed by ExcellGene scientists.
The orbital shaking of small bioreactors for high throughput of cell cultures was invented by Maria Wurm, a technology which is now industry standard and led to significant increases in yield due to the insights it provided.
Questions answered include:
- What characteristics make CHO cells extraordinary, and how can we make the most of them?
- What developmental steps in cell line development have led the technology which we have today?
- What challenges do we face in further improving processes and scale-up?
- What is orbital shaking, and why is it a great mixing method for cells?
- Which parts of the process have the biggest impact on cell yield?
- And a prediction for the development of the process in the 2030's.